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Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of 
the requirement for the degree of Master of Science 
 
DEVELOPMENT OF A RECOMBINANT RETROVIRUS EXPRESSING THE 
CHICKEN ANAEMIA VIRUS VP3 PROTEIN 
 
By 
SURIA MOHD SAAD 
September 2006 
 
Chairman : Professor Mohd Azmi Mohd Lila, PhD 
Faculty :      Veterinary Medicine 
 
Retrovirus is an infectious particle, hence it could be used as an efficient vector to 
deliver a desired gene product into mammalian cells. In this study, a recombinant viral 
vector was employed to carry a gene that induces apoptosis in various transformed and 
cancerous cell lines. The VP3 gene was cloned into pMSCV plasmid and the 
recombinant was used to transfect a packaging cell line to produce infectious 
replication-incompetent recombinant VP3-retrovirus. The sequence of the full length 
ORF encoding VP3 gene is similar to that of the reference CAV Cux-1 strain indicating 
that the VP3 gene was stably integrated into the RNA genome of the recombinant 
retrovirus. Real-time RT-PCR analysis showed virus production in packaging cells 
increased from day one, but gradually decreased on day three and day four and 
eventually were undetectable on day five post-infection. The number of packaging cells 
undergoing apoptosis was shown to be directly associated with recombinant VP3-
retrovirus replication and the rate of cell-to-cell infection. Cells infected by recombinant 
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VP3-retrovirus expressed the VP3 protein in transformed and cancerous cell lines as 
confirmed by indirect immunoperoxidase assay using anti-VP3 monoclonal antibody. 
The VP3 protein was detected primarily in the nucleus of infected cells, the site in which 
the protein is believed to initiate the cascade of programmed cell death or apoptosis. 
Apoptotic genomic DNA cleavage of the transformed cells was observed. Terminal 
deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assay 
confirmed the occurrence of apoptosis following infection by the recombinant VP3-
retrovirus. This study demonstrated the potential application of recombinant VP3-
retrovirus in cancer therapy. The current recombinant VP3-retrovirus construct may 
serve as an excellent prototype for the generation of alternative therapy to prevent the 
progressive growth of many types of cancer cells.  
 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
 
PEMBINAAN RETROVIRUS REKOMBINAN MENGEKSPRESKAN PROTEIN 
VP3 VIRUS ANAEMIA AYAM 
 
Oleh 
SURIA MOHD SAAD 
September 2006 
 
Pengerusi : Profesor Mohd Azmi Mohd Lila, PhD 
Fakulti : Perubatan Veterinar 
 
Retrovirus adalah partikel berjangkit, maka ia boleh digunakan sebagai vektor efisien 
untuk membawa produk gen yang diingini ke dalam sel-sel mamalia. Dalam kajian ini, 
vektor virus rekombinan digunakan untuk membawa gen yang meransang apoptosis 
dalam pelbagai lapisan sel terubah dan sel kanser. Gen VP3 diklonkan ke dalam plasmid 
pMSCV dan rekombinan digunakan untuk menjangkiti lapisan sel pembungkusan untuk 
menghasilkan VP3-retrovirus rekombinan berjangkit tidak mampu-mereplikasi. 
Penjujukan panjang keseluruhan rangka pembacaan terbuka pengkodan gen VP3 adalah  
sama dengan baka CAV Cux-1 rujukan menunjukkan yang gen VP3 secara stabil 
disatukan ke dalam genom RNA retrovirus rekombinan. Analisis RT-PCR masa-sebenar 
menunjukkan penghasilan virus dalam sel pembungkusan meningkat daripada hari 
pertama, tetapi menurun secara perlahan-lahan pada hari ketiga dan keempat dan 
akhirnya tidak dapat dikesan pada hari kelima selepas jangkitan. Bilangan sel 
pembungkusan menjalani apoptosis berkadar lansung dengan replikasi VP3-retrovirus 
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rekombinan dan kadar jangkitan sel ke sel. Sel-sel yang dijangkiti oleh VP3-retrovirus 
rekombinan mengekspreskan protein VP3 seperti yang disahkan melalui ujian 
immunoperoksidase tidak lansung menggunakan antibodi monoklonal anti-VP3. Protein 
VP3 dikesan terutamanya dalam nukleus sel-sel terjangkit, tempat dimana protein 
dipercayai memulakan urutan kematian sel terprogram atau apoptosis. Pemotongan 
DNA genomik apoptotik sel-sel terubah diperhatikan. Ujian perlabelan hujung celah 
perantaraan-transferase deoksinukleotidil terminal dUTP (TUNEL) mengesahkan 
kejadian apoptosis berikutan jangkitan oleh VP3-retrovirus rekombinan. Kajian ini 
menunjukkan potensi aplikasi VP3-retrovirus rekombinan dalam terapi kanser. 
Pembinaan VP3-retrovirus rekombinan terkini boleh bertindak sebagai prototaip terbaik 
terapi alternatif untuk mencegah pertumbuhan progresif pelbagai jenis sel kanser.  
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2.1 Model of apoptotic and survival signaling pathways involving 
members of the Bcl-2 family. (Left) Activation of the TNFα/Fas cell 
surface receptor leads to activation of caspase-8. Caspase-8 cleaves 
cytosolic p22 BID generating a p15 carboxyterminal fragment that 
translocates to the mitochondria resulting in the release of cytochrome 
c (cyt-c). Released cyt-c activates Apaf-1, which in turn activates a 
downstream caspase program. (Right) A death stimulus (IL-3 
deprivation) induces the translocation of BAX to the mitochondria 
where it is integral membrane and cross-linkable as a homodimer. 
(Center) Activation of the neural growth factor (NGF) or platelet-
derived growth factor (PDGF) receptors mediates the activation of 
Akt, resulting in the phosphorylation of BAD at Ser-136. Activation 
of the IL-3 receptor mediates the activation of the mitochondrial-
based protein kinase A (PKA) holoenzyme, resulting in the 
phosphorylation of BAD at Ser-112. Phosphorylated BAD is 
sequestered to the cytosol by the phosphoserine-binding protein 14-3-
3. (Source: Gross et al., 1999).   
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3.1 Physical map of the pMSCVneo vector. Note the multiple cloning 
sites (MCS) for the insertion of VP3 gene (Source: Clontech, USA, 
2002). 
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3.2 Restriction endonuclease (HindIII and XbaI) analysis of pcDNA-VP3. 
The recombinant plasmid DNAs was separated on a 1% agarose gel 
after HindIII and XbaI digestion of the pcDNA-VP3 which released 
the VP3 fragment (Lanes 1 to 4). M: 100 bp marker; Lanes 1 to 4: 
VP3 fragment. 
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3.3 Isolation of recombinant VP3-pMSCV vector (total DNA) from 
bacterial cells. Plasmid DNA was extracted from bacterial cells of 
transformed E. coli. The extraction product was electrophoresed in 
agarose/ethidium bromide stained gel and photographed under UV 
light. M: 1 kb marker; Lanes 1 to 3: total DNA sample extracted from 
bacterial cells. 
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3.4 Restriction endonuclease (EcoRI and XhoI) analysis of recombinant 
VP3-pMSCV vector. The recombinant plasmid DNAs was separated 
on a 1% agarose gel after EcoRI and XhoI digestion of the VP3-
pMSCV which released the VP3 fragment (Lanes 1 to 4). M: 100 bp 
marker; Lanes 1 to 4: VP3 fragment. 
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3.5 PCR amplification of VP3 gene from recombinant VP3-pMSCV 
vector. The amplified product was electrophoresed on a 1% agarose 
gel, stained with ethidium bromide and photographed under UV light. 
M: 100 bp marker; Lanes 1 to 7: specific amplification of VP3 gene 
from different clones at 400 bp.      
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established amino acid sequence of CAV strain Cux-1. The leucine at 
position 100 was replaced by proline residue. The nuclear localisation 
signal (NLS) comprised of amino acids 82 to 88 (NLS1) and amino 
acids 111 to 121 (NLS2).   
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4.1 Virus production in packaging cell lines. The gag, pol, and env genes 
required for viral production are integrated into the packaging cells 
genome. The vector provides the viral packaging signal, commonly 
denoted ψ+, a target gene and a drug-resistance marker. (Source: 
Clontech, USA, 2002). 
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4.2 A generalised retrovirus. Retroviral gene expression systems have 
divided the wild-type retroviral elements shown here into a dual 
system consisting of a packaging cell line and a retroviral vector. 
Viral genes required for replication, (gag, pol and env) are stably 
integrated into the genome of a cell to create a packaging cell line. 
The remaining elements of retroviral genome (LTRs and ψ+ sequence) 
provide the basis of the retroviral vector (Source: Clontech, USA, 
2002). 
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4.3 MTT assay. Percent cell viability against the concentration of 
antibiotic. The survival of cells decreased with increasing antibiotic 
concentration. 
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4.4 RT-PCR products electrophoresed on 2% agarose/EtBr gel. RNA was 
first reverse transcripts to cDNA by reverse transcriptase. The cDNA 
will act as a template in PCR and amplified by DNA polymerase. 
Lane 1: 100 bp DNA ladder. Lane 2, 3 and 4: specific amplification of 
VP3 gene at 400 bp. 
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4.7 A series of amplifications of standard RNA of recombinant VP3-
retrovirus illustrate the effects of initial template copy number on the 
fluorescence profile and a lack of specificity at low initial copy 
number. The initial template copy number was 10-4, 10-3, 10-2, 10-1 or 
100. The fluorescence profiles for the reactions with greater than 10-3 
initial copies of template are separated by about two amplifications 
cycle, while the low copy number reactions (10-4) showed no 
amplification. 
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4.8 The fluorescence profile of recombinant VP3-retrovirus RNA samples 
measured with the real-time RT-PCR. Amplification plot showing the 
change of fluorescence of SYBR green I dye plotted versus cycle 
number. Each reaction contained one sets of RT-PCR primers specific 
for unique VP3 nucleotide sequence. RNA samples are plotted from 
day 1 to day 5 post-infection.  
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4.9 Standard RNA concentration. The RNA concentration decreased with 
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4.10 Relationship of known number of total RNA transcripts to the CT. The 
CT is directly proportional to the log of the input copy equivalents, as 
demonstrated by the standard curve generated. Initial copies of target 
template recombinant VP3-retrovirus RNA in a sample can be 
estimated based on the linear relationship. 
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4.11 Recombinant VP3-retrovirus titre post-infection. The production of 
virus particles increased on day 1 and 2 post-infection. By day 3 post-
infection, the production of virus particles decreased and undetectable 
on day 5 post-infection. 
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5.1 The packaging cells produced the viral proteins, gag, pol and env and 
the vector sequences were transcribed into viral genomic DNA that 
can be packaged into a virus particle. This virus is capable of 
efficiently infecting a target cell, reverse transcribing the viral RNA, 
integrating the provirus into the cells genome and undergoing gene 
transcription of the desired transferred gene. Since the integrated 
provirus vector DNA contains none of the viral genes necessary for 
assembly of new virus particles, no further production of virus occurs 
(Source: Clontech, USA, 2002). 
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5.2 Comparison of the conventional method and the LM-PCR assay for 
detection of nucleosomal ladder. Panel A: Conventional method. The 
DNA was loaded directly on a 2% agarose/EtBr gel. M1: 1 kb DNA 
ladder. M2: 100 bp DNA ladder. Lane 1: extracted DNA of day 0. 
Lane 2: extracted DNA of day 1. Lane 3: extracted DNA of day 2. 
Lane 4: extracted DNA of day 3. Lane 5: extracted DNA of day 4. 
Lane 6: extracted DNA of day 5. Panel B: LM-PCR assay. Genomic 
DNA was isolated from recombinant VP3-retrovirus infected PT67 
cells and was used in the LM-PCR assay according to user manual (28 
PCR cycles). 10 µl of each reaction was electrophoresed on 1.8% 
agarose/EtBr gel. M: 1 kb DNA ladder. Lane 1: LM-PCR product of 
day 1. Lane 2: LM-PCR product of day 2. Lane 3: LM-PCR product 
of day 3. Lane 4: LM-PCR product of day 4. Lane5: LM-PCR product 
of day 5. Lane 6: LM-PCR product of day 6. Lane 7: PCR product of 
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5.3 Comparison of the conventional method and the LM-PCR assay for 
detection of nucleosomal ladder. Panel A: Conventional method. The 
DNA fragments were isolated from uninduced PT67 cells. 10 µl of 
each sample was electrophoresed on a 2% agarose/EtBr gel. M1: 1kb 
marker; M2: 100 bp marker. Total DNA extracted from PT67 cells at 
day 0 (Lane 1), day one (Lane 2), day two (Lane 3), day three (Lane 
4), day four (Lane 5) and day five (Lane 6) post-transfection. Panel 
B: LM-PCR assay. Genomic DNA was isolated from retrovirus 
infected PT67 cells and was used in the LM-PCR assay according to 
user manual (28 PCR cycles). 10 µl of each reaction was 
electrophoresed on 1.8% agarose/EtBr gel. M: 1 kb DNA ladder. Lane 
1: LM-PCR product of day 4. Lane 2: LM-PCR product of day 5. 
Lane 3: LM-PCR product of day 6.  
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5.4 Immunohistochemical analysis in cell cultures by indirect 
immunoperoxidase detection of VP3 protein expression in PT67 cells 
and examined by light microscope (LEICA MPS 60, Germany). A: 
PT67 cell infected with recombinant VP3-retrovirus (X40 
magnification) shows dark brown aggregates concentrated around the 
nucleus (red arrow head). B: PT67 cell infected with retrovirus (X40 
magnification) shows micro plaque, clustering of infected cells (green 
arrow head). C: Normal PT67 cells (X40 magnification) show 
confluent monolayer cells. 
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5.5 Immunohistochemical analysis in cell cultures by indirect 
immunoperoxidase detection of VP3 protein expression in VERO cell 
and examined by light microscope (LEICA MPS 60, Germany). A: 
VERO cell infected with recombinant VP3-retrovirus (X40 
magnification) shows dispersed dark brown droplet of chromatin (red 
arrow head). B: VERO cell infected with retrovirus (X40 
magnification) shows rounding of infected cells (green arrow head). 
C: Normal VERO cells (X40 magnification) show confluent 
monolayer cells without shape changes. 
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5.6 Immunohistochemical analysis in cell cultures by indirect 
immunoperoxidase detection of VP3 protein expression in MCF-7 and 
examined by light microscope (LEICA MPS 60, Germany). . A: 
MCF-7 cell infected with recombinant VP3-retrovirus (X40 
magnification) shows light brown stain of nucleus (red arrow head). 
B: MCF-7 cell infected with retrovirus (X40 magnification) shows 
rounding of infected cells formed micro plaque (green arrow head). C: 
Normal MCF-7 cells (X40 magnification) show confluent monolayer 
cells that retain the normal structures of cells. 
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5.7 The measurement of the fragmented DNA of apoptotic mouse 
fibroblast (PT67) cells by catalytically incorporating peroxidase-
dUTP at 3’-OH DNA ends using the enzyme Terminal 
Deoxynucleotidyl Transferase (TdT). Three days after infection, PT67 
cells were fixed and analysed by colorimetric TUNEL system, viewed 
under light microscope (LEICA MPS 60, Germany). A: PT67 cells 
infected with recombinant VP3-retrovirus (X40 magnification) 
exhibiting a complete peroxidase staining appeared as dark brown 
nucleus (red arrow head). B: PT67 cell infected with retrovirus 
(negative control) (X40 magnification) shows development of micro 
plaque (green arrow head). C: Non-infected PT67 cells (X40 
magnification).  
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5.8 Detection of apoptotic cell in colon carcinoma (CT26) cells by 
TUNEL assay. Three days after infection with recombinant VP3-
retrovirus, CT26 cells were fixed and analysed by in situ apoptotic 
cells detection, viewed under light microscope (LEICA MPS 60, 
Germany). A: CT26 cells infected with recombinant VP3-retrovirus 
(X40 magnification) exhibiting a complete peroxidase staining 
appeared as dark brown nucleus (red arrow head). B: CT26 cell 
infected with retrovirus as negative control (X40 magnification) 
shows dendritic shaped cells (green arrow head). C: Non-infected 
CT26 cells (X40 magnification). 
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5.9 
 
 
 
 
 
 
 
 
 
The apoptosis detection in VERO cultured cells by colorimetric 
TUNEL assay. Three days after infection with recombinant VP3-
retrovirus, VERO cells were fixed and analysed by TUNEL, viewed 
under light microscope (LEICA MPS 60, Germany). A: VERO cells 
infected with recombinant VP3-retrovirus (X40 magnification) show 
apoptotic body with its intact plasma membrane (red arrow head). B: 
X40 magnification of VERO cell infected with retrovirus (negative 
control) shows macro plaque (green arrow head). C: Non-infected 
VERO cells (X40 magnification). 
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5.10 The colorimetric TUNEL assay for specific detection of apoptotic 
human mammary carcinoma (MCF-7) cells. Three days after infection 
with recombinant VP3-retrovirus, MCF-7 cells were fixed and 
analysed by in situ apoptotic cells detection, viewed under light 
microscope (LEICA MPS 60, Germany). A: MCF-7 cells infected 
with recombinant VP3-retrovirus (X40 magnification). 
Hypercondensed chromatin (red arrow head) that could be ascribed to 
apoptotic cells, were observed in MCF-7 cells infected with 
recombinant VP3-retrovirus. B: MCF cell infected with retrovirus 
(negative control) (X40 magnification) with gigantic cell (green arrow 
head). C: Non-infected MCF-7 cells (X40 magnification).  
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5.11 The rapid and accurate detection of apoptotic cells in situ. Three days 
after infection with recombinant VP3-retrovirus, human embryonic 
kidney (HEK) cells were fixed and analysed by TUNEL, viewed 
under light microscope (LEICA MPS 60, Germany). A: HEK cells 
infected with recombinant VP3-retrovirus (X40 magnification) show 
polygonal cells (red arrow head). There is no dark brown aggregate in 
infected HEK cells, as VP3 only exert an apoptosis effect on 
transformed and tumour cells. B: HEK cells infected with retrovirus 
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(green arrow head). C: Normal HEK cells (X40 magnification).  
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UV Ultraviolet 
V Volt 
VERO African green monkey kidney cell 
v/v Volume per volume 
 xxv
 xxvi
VP Viral protein 
w/v Weight per volume 
WT Wild type 
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